434 related articles for article (PubMed ID: 19056224)
21. Orthopaedic-induced anemia: the fallacy of autologous donation programs.
Cushner FD; Hawes T; Kessler D; Hill K; Scuderi GR
Clin Orthop Relat Res; 2005 Feb; (431):145-9. PubMed ID: 15685068
[TBL] [Abstract][Full Text] [Related]
22. Red blood cell transfusions for elective hip and knee arthroplasty: opportunity to improve quality of care and documentation.
Cook SS; Cangialose CB; Sieburg DM; Kieszak SM; Boudreau R; Hoffman LH; Elward KS; Ballard DJ
Clin Perform Qual Health Care; 1999; 7(1):5-16. PubMed ID: 10351595
[TBL] [Abstract][Full Text] [Related]
23. Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: a prospective randomized clinical trial.
Moonen AF; Knoors NT; van Os JJ; Verburg AD; Pilot P
Transfusion; 2007 Mar; 47(3):379-84. PubMed ID: 17319816
[TBL] [Abstract][Full Text] [Related]
24. Two injections of erythropoietin correct moderate anemia in most patients awaiting orthopedic surgery.
Rosencher N; Poisson D; Albi A; Aperce M; Barré J; Samama CM
Can J Anaesth; 2005 Feb; 52(2):160-5. PubMed ID: 15684256
[TBL] [Abstract][Full Text] [Related]
25. Patient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients.
So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
Anesthesiology; 2014 Apr; 120(4):839-51. PubMed ID: 24424070
[TBL] [Abstract][Full Text] [Related]
26. Preoperative administration of epoetin alfa to reduce transfusion requirements in elderly patients having primary total hip or knee reconstruction.
Lofthouse RA; Boitano MA; Davis JR; Jinnah RH
J South Orthop Assoc; 2000; 9(3):175-81. PubMed ID: 12135299
[TBL] [Abstract][Full Text] [Related]
27. Quality of the blood sampled from surgical drainage after total hip arthroplasty.
Tripković B; Buković D; Sakić K; Sakić S; Buković N; Radaković B
Coll Antropol; 2008 Mar; 32(1):153-60. PubMed ID: 18494201
[TBL] [Abstract][Full Text] [Related]
28. A restrictive use of both autologous donation and recombinant human erythropoietin is an efficient policy for primary total hip or knee arthroplasty.
Couvret C; Laffon M; Baud A; Payen V; Burdin P; Fusciardi J
Anesth Analg; 2004 Jul; 99(1):262-271. PubMed ID: 15281542
[TBL] [Abstract][Full Text] [Related]
29. A randomized, parallel-group, open-label trial of recombinant human erythropoietin vs preoperative autologous donation in primary total joint arthroplasty: effect on postoperative vigor and handgrip strength.
Keating EM; Callaghan JJ; Ranawat AS; Bhirangi K; Ranawat CS
J Arthroplasty; 2007 Apr; 22(3):325-33. PubMed ID: 17400086
[TBL] [Abstract][Full Text] [Related]
30. Postoperative re-perfusion of drained blood in patients undergoing total knee arthroplasty: is it effective and cost-efficient?
Kirkos JM; Krystallis CT; Konstantinidis PA; Papavasiliou KA; Kyrkos MJ; Ikonomidis LG
Acta Orthop Belg; 2006 Jan; 72(1):18-23. PubMed ID: 16570889
[TBL] [Abstract][Full Text] [Related]
31. Perioperative autotransfusion in total hip and knee arthroplasty.
Clark CR; Spratt KF; Blondin M; Craig S; Fink L
J Arthroplasty; 2006 Jan; 21(1):23-35. PubMed ID: 16446182
[TBL] [Abstract][Full Text] [Related]
32. Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty.
Innerhofer P; Klingler A; Klimmer C; Fries D; Nussbaumer W
Transfusion; 2005 Jan; 45(1):103-10. PubMed ID: 15647025
[TBL] [Abstract][Full Text] [Related]
33. Autologous blood donation in total knee arthroplasties is not necessary.
Müller U; Röder C; Pisan M; Orler R; El-Kerdi A; Eggli S
Acta Orthop Scand; 2004 Feb; 75(1):66-70. PubMed ID: 15022810
[TBL] [Abstract][Full Text] [Related]
34. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery.
Cuenca J; García-Erce JA; Martínez F; Pérez-Serrano L; Herrera A; Muñoz M
Transfusion; 2006 Jul; 46(7):1112-9. PubMed ID: 16836557
[TBL] [Abstract][Full Text] [Related]
35. Pre-operative injections of epoetin-alpha versus post-operative retransfusion of autologous shed blood in total hip and knee replacement: a prospective randomised clinical trial.
Moonen AF; Thomassen BJ; Knoors NT; van Os JJ; Verburg AD; Pilot P
J Bone Joint Surg Br; 2008 Aug; 90(8):1079-83. PubMed ID: 18669967
[TBL] [Abstract][Full Text] [Related]
36. Preoperative use of recombinant human erythropoietin before total joint arthroplasty.
Bezwada HP; Nazarian DG; Henry DH; Booth RE
J Bone Joint Surg Am; 2003 Sep; 85(9):1795-800. PubMed ID: 12954840
[TBL] [Abstract][Full Text] [Related]
37. Autologous transfusion and other approaches to reduce allogeneic blood exposure.
Vamvakas EC; Pineda AA
Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):533-47. PubMed ID: 11102275
[TBL] [Abstract][Full Text] [Related]
38. Blood transfusion requirement prediction in patients undergoing primary total hip and knee arthroplasty.
Guerin S; Collins C; Kapoor H; McClean I; Collins D
Transfus Med; 2007 Feb; 17(1):37-43. PubMed ID: 17266702
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin as adjuvant to pre-operative autologous blood donation in total hip arthroplasty: new algorithm for use.
Vargas-Pabon M; Diaz-Trapiella A; Hurtado MJ; Diaz Varela N; Cerra Sabio JL
Transfus Apher Sci; 2005 Oct; 33(2):91-7. PubMed ID: 16109506
[TBL] [Abstract][Full Text] [Related]
40. A prospective audit of blood usage post primary total knee arthroplasty.
Glynn A; McCarthy T; McCarroll M; Murray P
Acta Orthop Belg; 2006 Jan; 72(1):24-8. PubMed ID: 16570890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
